跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
胸腔內科
醫學系
內科學科
電話
+886-2-22490088#2714
電子郵件
[email protected]
網站
http://medschool.tmu.edu.tw/main.php
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(18)
專案
(152)
研究成果
(1046)
資料集
(46)
指紋
查看啟用 胸腔內科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Non Small Cell Lung Cancer
72%
Lung Cancer
70%
Chronic Obstructive Lung Disease
65%
Inflammation
59%
Mouse
55%
Cohort Study
53%
Asthma
48%
Lung Adenocarcinoma
46%
Disease
42%
Sleep Disordered Breathing
42%
Malignant Neoplasm
38%
Neoplasm
37%
Phosphotransferase
37%
Thrombin
35%
Nuclear Factor
30%
Alternative Complement Pathway C3 C5 Convertase
30%
Connective Tissue Growth Factor
29%
Mycobacterium Tuberculosis
29%
Lung Tuberculosis
28%
Polycyclic Aromatic Hydrocarbon
27%
Chemotherapy
27%
Cyclooxygenase 2
27%
Multi-Drug-Resistant Tuberculosis
27%
Tuberculostatic Agent
27%
Epidermal Growth Factor Receptor Kinase Inhibitor
26%
Interleukin 6
26%
Biological Marker
25%
Adverse Event
25%
Tumor Necrosis Factor
25%
Rifampicin
22%
Quinolone Derivative
22%
Emphysema
21%
Mitogen Activated Protein Kinase
21%
Protein Tyrosine Kinase Inhibitor
20%
Overall Survival
20%
Cytokine
20%
Tuberculosis
20%
Progression Free Survival
20%
Drug Resistant Tuberculosis
19%
Protein Kinase C
19%
Infection
18%
Pleura Effusion
18%
Coronavirinae
18%
Isoniazid
17%
Randomized Controlled Trial
17%
Cytotoxicity
16%
Effusion
16%
Plasminogen Activator Inhibitor 1
16%
Diabetes Mellitus
16%
Long Term Exposure
16%
Transforming Growth Factor
16%
Fibrosis
15%
Zinc Oxide Nanoparticle
15%
Reactive Oxygen Metabolite
15%
Interleukin 8
15%
Uridine Triphosphate
15%
Small Interfering RNA
14%
Ovalbumin
14%
Carbon Black
14%
Prevalence
14%
Organic Carbon
13%
Lactate Dehydrogenase
13%
Endothelin 1
13%
Cell Viability
13%
Lipopolysaccharide
13%
Luciferase
13%
Chronic Kidney Failure
12%
Drug Resistance
12%
SARS Coronavirus
12%
Nitric Oxide
12%
Histone Deacetylase Inhibitor
12%
Immunotherapy
12%
Peptidoglycan
11%
Fibrinogen
11%
Erlotinib
11%
Cigarette Smoke
11%
Observational Study
11%
Apnea
10%
Metalloproteinase
10%
Transcription Factor AP 1
10%
Disintegrin
10%
Allergic Asthma
10%
Malignant Pleura Effusion
9%
Osimertinib
9%
Adenocarcinoma
9%
Western Blot
9%
Normal Human
9%
Disease Exacerbation
9%
Lung Disease
9%
Recurrent Disease
9%
Sleep Disorder
9%
Adenosine Triphosphate
9%
Inducible Nitric Oxide Synthase
9%
Placebo
9%
Pneumonia
9%
Calcium Ion
8%
Nanoparticle
8%
Comorbidity
8%
Uvomorulin
8%
Medicine and Dentistry
Lung Cancer
66%
Epidermal Growth Factor Receptor
60%
Chronic Obstructive Pulmonary Disease
56%
Cohort Analysis
54%
Multidrug Resistant Tuberculosis
47%
Non Small Cell Lung Cancer
47%
Lung Tuberculosis
41%
Meta-Analysis
37%
Obstructive Sleep Apnea
35%
Particular Matter 2.5
35%
Asthma
32%
Hazard Ratio
29%
Tuberculosis Treatment
27%
Lung Adenocarcinoma
26%
Disease
24%
Infection
23%
Atmospheric Aerosol
23%
Medicine
23%
COVID-19
23%
Odds Ratio
22%
Systematic Review
22%
Diabetes Mellitus
21%
Drug Resistant Tuberculosis
21%
Neoplasm
20%
Pleura Effusion
17%
Chronic Kidney Disease
16%
Mycobacterium Tuberculosis
16%
Prevalence
16%
Phosphotransferase
16%
Plasminogen Activator Inhibitor-1
16%
Overall Survival
16%
Tyrosine-Kinase Inhibitor
16%
Tuberculosis
15%
Tuberculostatic Agent
15%
Rifampicin
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Quinolone Derivative
15%
Biological Marker
14%
Retrospective Cohort Study
14%
Malignant Neoplasm
14%
In Vitro
14%
Metastatic Carcinoma
14%
Effusion
13%
Adverse Event
13%
Emphysema
13%
Epidermal Growth Factor Receptor Kinase Inhibitor
13%
Cancer Cell
13%
Patient-Data
13%
Programmed Cell Death
13%
Observational Study
13%
Intensive Care Unit
13%
Mesothelial Cell
13%
Non-Small Cell Lung Cancer
12%
Tumor Necrosis Factor
12%
Smoking
12%
Polycyclic Aromatic Hydrocarbon
12%
Diagnosis
12%
Systemic Lupus Erythematosus
11%
Isoniazid
11%
Influenza Vaccination
11%
Progression Free Survival
11%
Drug Sensitivity
11%
Sepsis
10%
Proportional Hazards Model
10%
Personalized Medicine
10%
Drug Resistance
10%
Fine Particulate Matter
9%
4 Iodo 2,5 Dimethoxyamphetamine
9%
Amino Terminal Sequence
9%
Diabetes
9%
Cytotoxicity
9%
Computer Assisted Tomography
9%
Symptom
9%
Exon
8%
Rheumatoid Arthritis
8%
Bronchoscopy
8%
Chest Radiograph
8%
Injury
8%
Drug Therapy
8%
Cancer
8%
Macrophage
8%
Cytokine
8%
Recurrent Disease
8%
Extensively Drug Resistant Tuberculosis
8%
Apoplexy
8%
Pulmonary Rehabilitation
8%
Epithelial Cell
8%
Silo-Filler's Disease
8%
Nucleic Acid Amplification
8%
Health Care Cost
8%
Logistic Regression Analysis
7%
Forced Expiratory Volume
7%
Cross Sectional Study
7%
Malignant Pleural Effusion
7%
Tretinoin
7%
Pleural Fibrosis
7%
Low Drug Dose
7%
Mortality Rate
7%
Sputum Culture
7%
Hypopnea
7%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
44%
Kinase
38%
Phosphotransferase
37%
Cohort Study
34%
Fibroblast
31%
Connective Tissue Growth Factor
25%
Macrophage
19%
Interleukin 8
17%
Particulate Matter
17%
Thrombin
16%
K-Complex
15%
Breathing
14%
Cancer Cell
12%
Body Mass
12%
Small Interfering RNA
11%
Lung Function
11%
Mycobacterium Tuberculosis
10%
Prevalence
10%
Tyrosine Kinase Inhibitor
10%
Retrospective Study
9%
Heart Rate Variability
9%
Cyclooxygenase
9%
Promoter Region
9%
Overall Survival
9%
Upregulation
9%
N-Terminus
9%
down Regulation
9%
Hemodialysis
8%
Platelet
8%
Metalloproteinase
8%
Metalloendopeptidase
8%
Extracellular Signal-Regulated Kinases
8%
Drug Resistance
8%
Messenger RNA
8%
Signal Transduction
8%
Luciferase
7%
Smoking
7%
Oxidative Stress
7%
Tretinoin
7%
Disintegrin
7%
Heavy Chain
7%
Observational Study
7%
Protein Kinase C
7%
Autophagy
7%
Immune Checkpoints
7%
Cell Death
7%
Lipopolysaccharide
7%
Blood Level
7%
Proteomics
7%
AP-1 Transcription Factor
7%
Normal Human
7%
P38 Mitogen-Activated Protein Kinases
6%
Eicosanoid Receptor
6%
Mouse
6%
Oxygen Desaturation
6%
Systolic Blood Pressure
6%
Endothelin 1
6%
Transforming Growth Factor
6%
Forced Expiratory Volume
6%
Ccaat-Enhancer-Binding Proteins
6%
Western Blot
6%
Genotyping
6%
Blood Pressure
5%
Histone Deacetylase
5%
Body Water
5%
Peptidoglycan
5%
Inter-Alpha-Trypsin Inhibitor
5%
Agonist
5%
Protein Expression
5%
Angiogenesis
5%
Computer Assisted Tomography
5%
Immunocompetent Cell
5%
Gene Expression
5%
Monospecific Antibody
5%
Exon
5%
Wild Type
5%
Progression Free Survival
5%
Medline
5%
T Cell
5%
C-Reactive Protein
5%
Complement Factor B
5%
Leukocyte
5%
Random Forest
5%
Tumor Progression
5%
Genetics
5%
Mitogen-Activated Protein Kinase
5%
Survival Rate
5%
Nitric Oxide Synthase
5%
Interleukin-6
5%